|
2023
|
Invention
|
Compounds having triple activities of thrombolysis, antithrombotic and radical scavenging.
The p... |
|
2022
|
Invention
|
Compositions and methods for treating pruritus.
Disclosed herein are topical pharmaceutical comp... |
|
2021
|
Invention
|
Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester.
The present in... |
|
|
Invention
|
Single-domain antibody-cytosine deaminase fusion proteins.
The disclosure relates to fusion prot... |
|
2019
|
Invention
|
Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester. The present inv... |
|
|
Invention
|
Compositions and methods for treating pruritus. Disclosed herein are topical pharmaceutical compo... |
|
|
Invention
|
Single-domain antibody-cytosine deaminase fusion proteins. Disclosed are fusion proteins, methods... |
|
2018
|
Invention
|
Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting. The presen... |
|
|
Invention
|
Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and rad... |
|
2015
|
Invention
|
Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synth... |
|
2014
|
Invention
|
New compounds having triple activities of thrombolysis, antithrombotic and radical scavenging, an... |
|
2013
|
Invention
|
Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as we... |
